AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli defense firms target Asia as Singapore Airshow opens amid regional arms race
2
Chinese fund: “The Chinese government has imposed a ban on any new investment in Israel”
3
Medtronic to acquire Israeli AI cardiology firm CathWorks for $585 million, deal could reach $1 billion
4
Cyera employees to sell tens of millions in shares at $9 billion valuation
5
Israeli startup raises $6.2 million to turn social media video into intelligence
More news

Varonis

6 stories about Varonis
בניין חברת ורוניס בהרצליה פיתוח

Varonis shares plunge 45% after surprise earnings miss

29.10.25|Sophie Shulman
Investors punish Israeli-founded cyber firm for lack of warning as cloud shift raises doubts about long-term strategy.
יקי פייטלסון מייסד ו מנכ"ל ורוניס

Varonis acquires SlashNext for $150 million in AI email security push

02.09.25|Sophie Shulman
Acquisition of California startup strengthens Israeli firm’s defenses against phishing and AI-driven attacks. 
Apex Founders

Sam Altman-backed Apex Security in advanced talks to be acquired by Varonis for up to $40M

21.01.25|Meir Orbach
The acquisition would strengthen Varonis' AI security capabilities. Apex denies the negotiations.
מוסף שבועי 22.2.24 הזמרת מארינה מקסימיליאן באירוע ההנפקה של פייוניר

Party on? High-tech's delicate dance navigating festivities in times of turmoil

26.02.24|Diana Bahur-Nir
As the war in Gaza wages on, the Israeli high-tech industry deals with shifting from a culture of fun and excess to raising employee morale modestly in a manner "adapted to the situation"
ה מפונים ב משרדי ורוניס

Good offices: Varonis opens doors, hearts to evacuees

12.11.23|Diana Bahur Nir
With the outbreak of war, Varonis took in 250 evacuees in its offices in Herzliya. "We essentially turned into a hotel," said CFO and COO Guy Melamed. A week later, Varonis moved them to a hotel that it paid for from the workers' days off.
בניין חברת ורוניס בהרצליה פיתוח

Varonis lays off 110 employees, downsizes R&D staff

06.11.22|Sophie Shulman
The Nasdaq-traded firm saw its share price plummet by more than a third last week following its disappointing results for the third quarter of the year